Unknown

Dataset Information

0

Structures of the class D carbapenemase OXA-24 from Acinetobacter baumannii in complex with doripenem.


ABSTRACT: The emergence of class D ?-lactamases with carbapenemase activity presents an enormous challenge to health practitioners, particularly with regard to the treatment of infections caused by Gram-negative pathogens such as Acinetobacter baumannii. Unfortunately, class D ?-lactamases with carbapenemase activity are resistant to ?-lactamase inhibitors. To better understand the details of the how these enzymes bind and hydrolyze carbapenems, we have determined the structures of two deacylation-deficient variants (K84D and V130D) of the class D carbapenemase OXA-24 with doripenem bound as a covalent acyl-enzyme intermediate. Doripenem adopts essentially the same configuration in both OXA-24 variant structures, but varies significantly when compared to the non-carbapenemase class D member OXA-1/doripenem complex. The alcohol of the 6? hydroxyethyl moiety is directed away from the general base carboxy-K84, with implications for activation of the deacylating water. The tunnel formed by the Y112/M223 bridge in the apo form of OXA-24 is largely unchanged by the binding of doripenem. The presence of this bridge, however, causes the distal pyrrolidine/sulfonamide group to bind in a drastically different conformation compared to doripenem bound to OXA-1. The resulting difference in the position of the side-chain bridge sulfur of doripenem is consistent with the hypothesis that the tautomeric state of the pyrroline ring contributes to the different carbapenem hydrolysis rates of OXA-1 and OXA-24. These findings represent a snapshot of a key step in the catalytic mechanism of an important class D enzyme, and might be useful for the design of novel inhibitors.

SUBMITTER: Schneider KD 

PROVIDER: S-EPMC3057435 | biostudies-literature | 2011 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structures of the class D carbapenemase OXA-24 from Acinetobacter baumannii in complex with doripenem.

Schneider Kyle D KD   Ortega Caleb J CJ   Renck Nicholas A NA   Bonomo Robert A RA   Powers Rachel A RA   Leonard David A DA  

Journal of molecular biology 20110106 4


The emergence of class D β-lactamases with carbapenemase activity presents an enormous challenge to health practitioners, particularly with regard to the treatment of infections caused by Gram-negative pathogens such as Acinetobacter baumannii. Unfortunately, class D β-lactamases with carbapenemase activity are resistant to β-lactamase inhibitors. To better understand the details of the how these enzymes bind and hydrolyze carbapenems, we have determined the structures of two deacylation-deficie  ...[more]

Similar Datasets

| S-EPMC3358182 | biostudies-literature
| S-EPMC89912 | biostudies-literature
| S-EPMC7666985 | biostudies-literature
| S-EPMC2715606 | biostudies-literature
| S-EPMC4023756 | biostudies-literature
| S-EPMC3393087 | biostudies-literature
| S-EPMC1891364 | biostudies-literature
| S-EPMC5119573 | biostudies-literature
| S-EPMC1563549 | biostudies-literature
| S-EPMC10135033 | biostudies-literature